Human genetic variants of pituitary adenylate cyclase-activating polypeptide (PACAP) or its receptors have been associated with psychiatric disorders, including post-traumatic stress disorder, anxiety, and depression [14, 15]. Here, ADCYAP1 is linked to depressive disorder.